Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
Jain, S., Cohen, J., Ward, M.M., Kornhauser, N., Chuang, E., Cigler, T., Moore, A., Donovan, D., Lam, C., Cobham, M.V., Schneider, S., Hurtado Rúa, S.M., Benkert, S., Mathijsen Greenwood, C., Zelkowitz, R., Warren, J.D., Lane, M.E., Mittal, V., Rafii, S., Vahdat, L.T.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Abstract P1-10-10: Tumor infiltrating lymphocytes (TILS) among high risk for recurrence breast cancer patients treated with tetrathimolybdate (TM)
Rybstein, MD, Nackos, E, Kornhauser, N, Cigler, T, Andreopoulou, E, Moore, A, Cobham, M, Fitzpatrick, V, Demaria, S, Vahdat, LT
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract PD9-07: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
Liu, YL, Bager, CL, Willumsen, N, Kornhauser, N, Cobham, M, Andreopoulou, E, Cigler, T, Moore, A, LaPolla, D, Fitzpatrick, V, Ward, M, Warren, JD, Mittal, V, Vahdat, LT
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P1-10-02: A phase II study of copper-depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence: Updated results
Sahota, S, Willis, A, Kornhauser, N, Ward, M, Cobham, M, Cigler, T, Moore, A, Andreopoulou, E, Fitzpatrick, V, Schneider, S, Prima, N, Wiener, A, Ko, D, De Laurentiis, A, Warren, JD, Rubinchik, A, Mittal, V, Vahdat, LT
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P3-02-02: Targeting the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence
Nackos, E, Willis, A, Kornhauser, N, Ward, M, Andreopoulou, E, Cigler, T, Moore, A, Fitzpatrick, V, Cobham, M, Schneider, S, Wiener, A, Guillaume-Abraham, J, Warren, JD, Rubinchik, A, Lane, M, Mittal, V, Vahdat, L
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P6-11-04: Targeting the tumor microenvironment: tetrathiomolybdate decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
Jain, S, Kornhauser, N, Lam, C, Ward, MM, Chuang, E, Cigler, T, Moore, A, Donovan, D, Cobham, MV, Schneider, S, Hurtado, Rua SM, Lane, ME, Mittal, V, Vahdat, LT
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article